| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | -0.11 | 0.006 |
| mRNA | erismodegib | CTRPv2 | pan-cancer | AAC | -0.11 | 0.006 |
| mRNA | Dasatinib | GDSC1000 | pan-cancer | AAC | 0.15 | 0.006 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | 0.085 | 0.006 |
| mRNA | OSI-906 | CTRPv2 | pan-cancer | AAC | -0.097 | 0.006 |
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | -0.091 | 0.007 |
| mRNA | erastin | CTRPv2 | pan-cancer | AAC | -0.097 | 0.007 |
| mRNA | valdecoxib | CTRPv2 | pan-cancer | AAC | -0.097 | 0.007 |
| mRNA | BRD-K84807411 | CTRPv2 | pan-cancer | AAC | 0.2 | 0.007 |
| mRNA | hyperforin | CTRPv2 | pan-cancer | AAC | -0.11 | 0.007 |